It was hypothesized that astragalin might hinder the progression of AP by modulating the NLRP3 signaling pathway, and concurrently, gut microbiota was an indispensable part in the relief of pancreatic histopathological processes mediated by astragalin. The gene discussed is NLRP3; the disease is alkaline phosphatase measurement.